↓ Skip to main content

Dove Medical Press

Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib

Overview of attention for article published in OncoTargets and therapy, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
16 Mendeley
Title
Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib
Published in
OncoTargets and therapy, April 2019
DOI 10.2147/ott.s194768
Pubmed ID
Authors

Zhengxing Gao, Chunqing Song, Guangxin Li, Haishan Lin, Xiangyao Lian, Ninggang Zhang, Bangwei Cao

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 31%
Researcher 5 31%
Student > Doctoral Student 1 6%
Unspecified 1 6%
Student > Master 1 6%
Other 1 6%
Unknown 2 13%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 25%
Medicine and Dentistry 3 19%
Biochemistry, Genetics and Molecular Biology 3 19%
Veterinary Science and Veterinary Medicine 1 6%
Unspecified 1 6%
Other 2 13%
Unknown 2 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2022.
All research outputs
#4,451,815
of 25,728,855 outputs
Outputs from OncoTargets and therapy
#172
of 3,013 outputs
Outputs of similar age
#86,982
of 365,494 outputs
Outputs of similar age from OncoTargets and therapy
#7
of 102 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,013 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,494 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.